MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET Long-term Investments
Investments the company intends to hold for more than a year.
MetLife, Inc.NYSE: MET
Long-term Investments · Q2 FY2026 · quarter ended Jun 2026
Long-term investments rises 3.7% from a year ago
Long-term investments stood at $365.87B at the end of Q2 FY2026, up 3.7% from a year earlier and up 1.3% from the prior quarter. Over 3 fiscal years it compounded at +39.1% a year.
Context
- Long-term investments amounted to 48.2% of total assets at the end of Q2 FY2026, down 2.0 pp from a year earlier.
- Long-term investments increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether long-term investments keeps rising in the next quarterly balance sheet after a +3.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 362.81B USD
- Year-over-year change
- +4.7%
- 4-year CAGR
- +25.3%
| Period | Period end | Long-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 362.81B | +4.7% |
| FY2024 | 2024-12-31 | 346.67B | +140.4% |
| FY2023 | 2023-12-31 | 144.19B | +6.9% |
| FY2022 | 2022-12-31 | 134.83B | -8.5% |
| FY2021 | 2021-12-31 | 147.37B | — |
Long-term Investments vs competitors
How MET compares with its peers on the latest reported figures
- Peers report in different currencies, so long-term investments is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +3.7% is the 5th highest of 11, against a peer median of -0.5%.
- Long-term investments amounts to 48.2% of total assets for MET, versus a peer median of 32.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | CA$455.54B CAD | +10.5% | +59.1% | 41.6% | |
| Jun 2026 | $365.87B USD | +3.7% | +39.1% | 48.2% | |
| Jun 2026 | $159.54B USD | +379.8% | — | 87.2% | |
| Jun 2026 | $108.55B USD | -72.3% | +65.2% | 13.9% | |
| Jun 2026 | $101.16B USD | +3.3% | +60.2% | 23.5% | |
| Jun 2026 | $43.7B USD | -4.4% | -0.1% | 68.8% | |
| Jun 2026 | $22.52B USD | +8.3% | +80.1% | 56.6% | |
| Jun 2026 | $20.59B USD | +742.9% | +17.3% | 65.2% | |
| Jun 2026 | $9.35B USD | -89.3% | -29.7% | 8.1% | |
| Sep 2026 | $0 USD | -100.0% | -6.5% | 0.0% | |
| Sep 2026 | $0 USD | -100.0% | -42.4% | 0.0% | |
| Peer median (excluding MET) | — | -0.5% | +17.3% | 32.6% | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 20.05B | 20.2B | 20.64B | 20.07B | 22.03B |
| Short-term Investments | 347.45B | 293.13B | 296.19B | 88.71B | 103.31B |
| Net Receivables | 20.52B | 22.17B | 33.78B | 34.26B | 54.25B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 388.02B | 335.49B | 350.62B | 143.04B | 179.59B |
| Property, Plant & Equipment (Net) | 0 | 1.93B | 1.99B | 1.85B | 1.7B |
| Goodwill | 9.54B | 9.3B | 9.24B | 8.9B | 9.61B |
| Intangible Assets | 16.06B | 19.65B | 20.15B | 19.63B | 21.11B |
| Long-term Investments | 147.37B | 134.83B | 144.19B | 346.67B | 362.81B |
| Tax Assets | 189M | 2.44B | 2.61B | 2.99B | 2.59B |
| Other Non-current Assets | 198.54B | 159.44B | 158.79B | 154.38B | 167.77B |
| Total Non-current Assets | 371.69B | 327.58B | 336.97B | 534.42B | 565.58B |
| Total Assets | 759.71B | 663.07B | 687.58B | 677.46B | 745.17B |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 341M | 175M | 119M | 465M | 1.56B |
| Tax Payables | 0 | 42M | 190M | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 230.92B | 229.97B | 239.93B | 240.48B | 257.46B |
| Total Current Liabilities | 263.18B | 251.08B | 257.58B | 258.07B | 276.14B |
| Long-term Debt | 17.09B | 17.75B | 18.68B | 18.24B | 18.62B |
| Deferred Tax Liabilities | 9.69B | 950M | 927M | 132M | 536M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 402B | 363.11B | 380.12B | 373.3B | 420.95B |
| Total Non-current Liabilities | 428.78B | 381.86B | 399.76B | 391.69B | 440.11B |
| Total Liabilities | 691.96B | 632.95B | 657.33B | 649.75B | 716.25B |
| Common Stock | 12M | 12M | 12M | 12M | 12M |
| Retained Earnings | 41.2B | 40.33B | 40.15B | 42.63B | 44.29B |
| Accumulated OCI | 10.92B | (22.62B) | (19.24B) | (21.19B) | (18.08B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 267M | 244M | 238M | 258M | 523M |
| Total Equity | 67.75B | 30.13B | 30.25B | 27.7B | 28.92B |
| Total Debt | 17.43B | 17.98B | 18.83B | 18.72B | 20.18B |
| Net Debt | (2.62B) | (2.22B) | (1.81B) | (1.35B) | (1.85B) |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.